Stifel Financial Corp Lian Bio Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.33 - $4.6 $619 - $2,143	466 Added 2.58%	18,500 $82,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.85 $9,845 - $15,675	-5,500 Reduced 23.37%	18,034 $41,000
Q1 2023 May 12, 2023	BUY	$1.57 - $2.66 $3,585 - $6,075	2,284 Added 10.75%	23,534 $46,000
Q4 2022 Feb 13, 2023	BUY	$1.14 - $2.11 $24,224 - $44,837	21,250 New	21,250 $34,000

1.09M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.